84.      Matthews P.C., Campbell C., Sandulescu O., Maticic M., Ruta S.M., Rivero-Juarez A., Van Welzen B.J., Tan B.K., Garcia F., Gherlan G.S., Cinar G., Hasanoglu I., Gmizic I., Nicolini L.A., Santos L., Sargsyants N., Velikov P., Habibovic S., Fourati S., Zidovec-Lepej S., Herder V., Dudman S., Miron V.D., Irving W., Sahin G.O., E E.S.G.V.H. Acute severe hepatitis outbreak in children: A perfect storm. What do we know, and what questions remain? Frontiers in Pharmacology 2022, 13, doi:10.3389/fphar.2022.1062408.

83.      Cristescu C.V., Ghica M., Udeanu D.I., Amzar A.I., Dita C., Grancea C., Siliste R., Vintila A.M., Homentcovschi C.S., Alain S., Ruta S. CYTOMEGALOVIRUS INFECTION AND CARDIOVASCULAR RISK IN A MONOCENTRIC ROMANIAN ADULT PATIENT GROUP. Farmacia 2022, 70, 300-306, doi:10.31925/farmacia.2022.2.16.

82.      Lupascu R.E., Ilie M.I., Velescu B.S., Udeanu D.I., Sultana C., Ruta S., Arsene A.L. COVID-19-Current Therapeutical Approaches and Future Perspectives. Processes 2022, 10, doi:10.3390/pr10061053.

81.      Iacob D.G., Luminos M., Benea O.E., Tudor A.M., Olariu C.M., Iacob S.A., Ruta S. Liver fibrosis progression in a cohort of young HIV and HIV/HBV co-infected patients: A longitudinal study using non-invasive APRI and Fib-4 scores. Frontiers in Medicine 2022, 9, doi:10.3389/fmed.2022.888050.

80.      Cristescu C.V., Alain S., Ruta S.M. The Role of CMV Infection in Primary Lesions, Development and Clinical Expression of Atherosclerosis. Journal of Clinical Medicine 2022, 11, doi:10.3390/jcm11133832.

79.      Chivu-Economescu M., Vremera T., Ruta S.M., Grancea C., Leustean M., Chiriac D., David A., Matei L., Diaconu C.C., Gatea A., Ilie C., Radu I., Cornienco A.M., Iancu L.S., Cirstoiu C., Pop C.S., Petru R., Strambu V., Malciolu S., Popescu C.P., Florescu S.A., Rafila A., Furtunescu F.L., Pistol A. Assessment of the Humoral Immune Response Following COVID-19 Vaccination in Healthcare Workers: A One Year Longitudinal Study. Biomedicines 2022, 10, doi:10.3390/biomedicines10071526.

78.      Chivu-Economescu M., Bleotu C., Grancea C., Chiriac D., Botezatu A., Iancu I.V., Pitica I., Necula L.G., Neagu A., Matei L., Dragu D., Sultana C., Radu E.L., Nastasie A., Voicu O., Ataman M., Nedeianu S., Mambet C., Diaconu C.C., Ruta S.M. Kinetics and persistence of cellular and humoral immune responses to SARS-CoV-2 vaccine in healthcare workers with or without prior COVID-19. Journal of Cellular and Molecular Medicine 2022, 26, 1293-1305, doi:10.1111/jcmm.17186.

77.      Sultana C., Casian M., Oprea C., Ianache I., Grancea C., Chiriac D., Ruta S. Hepatitis B Virus Genotypes and Antiviral Resistance Mutations in Romanian HIV-HBV Co-Infected Patients. Medicina-Lithuania 2022, 58, doi:10.3390/medicina58040531.

76.      Popescu C.P., Cotar A.I., Dinu S., Zaharia M., Tardei G., Ceausu E., Badescu D., Ruta S., Ceianu C.S., Florescu S.A. Emergence of Toscana Virus, Romania, 2017-2018. Emerging Infectious Diseases 2021, 27, 1482-1485, doi:10.3201/eid2705.204598.

75.      Popescu C.P., Zaharia M., Nica M., Stanciu D., Moroti R., Benea S., Melinte V., Vasile T., Ceausu E., Ruta S., Florescu S.A. Anthrax meningoencephalitis complicated with brain abscess-A case report. International Journal of Infectious Diseases 2021, 108, 217-219, doi:10.1016/j.ijid.2021.05.013.

74.      D’haese S., Lacroix C., Garcia F., Plana M., Ruta S., Vanham G., Verrier B., Aerts J.L. Off the beaten path: Novel mRNA-nanoformulations for therapeutic vaccination against HIV. Journal of Controlled Release 2021, 330, 1016-1033, doi:10.1016/j.jconrel.2020.11.009.

73.      Balan A., Bejan I., Bonciu S., Eni C.E., Ruta S. Romanian Medical Students’ Attitude towards and Perceived Knowledge on COVID-19 Vaccination. Vaccines 2021, 9, doi:10.3390/vaccines9080854.

72.      Popescu C.P., Florescu S.A., Ruta S.M. West Nile virus in Central Europe – Pandora’s box is wide open! Travel Medicine and Infectious Disease 2020, 37, doi:10.1016/j.tmaid.2020.101864.

71.      Dragu D.L., Neagu A.I., Matei L., Bleotu C., Ruta S.M., Diaconu C.C. Characterization of a platform based on dendritic cells for new therapeutic vaccine development. Romanian Biotechnological Letters 2020, 25, 1899-1907, doi:10.25083/rbl/25.5/1899.1907.

70.      Popescu C.P., Marin A., Melinte V., Gherlan G.S., Banicioiu F.C., Dogaru A., Smadu S., Veja A.M., Nedu E., Stanciu D., Voinescu B., Simion V., Toderan A., Dascalu A., Oprisan C., Tardei G., Nica M., Ceausu E., Ruta S.M., Florescu S.A. COVID-19 in a tertiary hospital from Romania: Epidemiology, preparedness and clinical challenges. Travel Medicine and Infectious Disease 2020, 35, doi:10.1016/j.tmaid.2020.101662.

69.      Temereanca A., Ene L., Rosca A., Diaconu C.C., Luca A., Burlacu R., Radoi R., Bulacu-Talnariu A., Marcotte T.D., Achim C.L., Ruta S. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection. Aids Research and Human Retroviruses 2020, 36, 367-372, doi:10.1089/aid.2019.0132.

68.      Iacob D.G., Rosca A., Ruta S.M. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World Journal of Gastroenterology 2020, 26, 1113-1127, doi:10.3748/wjg.v26.i11.1113.

67.      Rosca A., Iacob D., Ene L., Temereanca A., Grancea C., Sultana C., Achim C.L., Ruta S. LIVER FUNCTION IN A COHORT OF YOUNG HIV-HBV CO-INFECTED PATIENTS ON LONG-TERM COMBINED ANTIRETROVIRAL THERAPY. Farmacia 2020, 68, 42-47, doi:10.31925/farmacia.2020.1.7.

66.      Popescu C.P., Florescu S.A., Hasbun R., Harxhi A., Evendar R., Kahraman H., Neuberger A., Codreanu D., Zaharia M.F., Tosun S., Ceausu E., Ruta S.M., Dragovac G., Pshenichnaya N., Gopatsa G., Shmaylenko O., Nagy E., Malbasa J.D., Strbac M., Pandak N., Pullukcu H., Lakatos B., Cag Y., Cascio A., Coledan I., Oncu S., Erdem H. Prediction of unfavorable outcomes in West Nile virus neuroinvasive infection – Result of a multinational ID-IRI study. Journal of Clinical Virology 2020, 122, doi:10.1016/j.jcv.2019.104213.

65.      Burlacu R., Umlauf A., Marcotte T.D., Soontornniyomkij B., Diaconu C.C., Bulacu-Talnariu A., Temereanca A., Ruta S.M., Letendre S., Ene L., Achim C.L. Plasma CXCL10 correlates with HAND in HIV-infected women. Journal of Neurovirology 2020, 26, 23-31, doi:10.1007/s13365-019-00785-4.

64.      Ruta S., Burlacu R., Ene L., Umlauf A., Diaconu C., Rosca A., Temereanca A., Bulacu-Talnariu A., Soontornniyomkij B., Marcotte T., Achim C. Determinants of neurocognitive impairments in a Romanian cohort of young adults with chronic HIV infection. Hiv Medicine 2019, 20, 310-310.

63.      Sultana C., Rosca A., Ruta S. Correlation Between miR-125b Expression and Liver Fibrosis in Patients with Chronic Hepatitis C. Hepatitis Monthly 2019, 19, doi:10.5812/hepatmon.84615.

62.      Oprea C., Ianache I., Calistru P.I., Nica M., Ruta S., Smith C., Lipman M. Increasing incidence of HIV- associated tuberculosis in Romanian injecting drug users. Hiv Medicine 2018, 19, 316-323, doi:10.1111/hiv.12576.

61.      Popescu C.P., Florescu S.A., Cotar A.I., Badescu D., Ceianu C.S., Zaharia M., Tardei G., Codreanu D., Ceausu E., Ruta S.M. Re-emergence of severe West Nile virus neuroinvasive disease in humans in Romania, 2012 to 2017-implications for travel medicine. Travel Medicine and Infectious Disease 2018, 22, 30-35, doi:10.1016/j.tmaid.2018.03.001.

60.      Sultana C., Schweitzer A.M., Bogdan M., Ruta S. Are HIV, HBV and HCV Voluntary Counseling and Testing Programs Needed in Balkans? Balkan Medical Journal 2018, 35, 219-220, doi:10.4274/balkanmedj.2017.1229.

59.      Ester C., Cerban R., Iacob S., Pietrareanu C., Constantin G., Paslaru L., Ichim S., Lita M., Vadan R., Grancea C., Ruta S., Gheorghe C., Popescu I., Gheorghe L. The Role of Beta-7 Integrin and Carbonic Anhydrase IX in Predicting the Occurrence of de Novo Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. Chirurgia 2018, 113, 534-541, doi:10.21614/chirurgia.113.4.534.

58.      Burlacu R., Umlauf A., Luca A., Gianella S., Radoi R., Ruta S.M., Marcotte T.D., Ene L., Achim C.L. Sex-based differences in neurocognitive functioning in HIV-infected young adults. Aids 2018, 32, 217-225, doi:10.1097/qad.0000000000001687.

57.      Leblebicioglu H., Arends J.E., Ozaras R., Corti G., Santos L., Boesecke C., Ustianowski A., Duberg A.S., Ruta S., Salkic N.N., Husa P., Lazarevic I., Pinede J.A., Pshenichnaya N.Y., Tsertswadze T., Maticic M., Puca E., Abuova G., Gervain J., Bayramli R., Ahmeti S., Koulentaki M., Kilani B., Vince A., Negro F., Sunbul M., Salmon D., Esghv. Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries. Antiviral Research 2018, 150, 9-14, doi:10.1016/j.antiviral.2017.12.001.

56.      Burlacu R., Umlauf A., Marcotte T., Soontornniyomkij B., Diaconu C., Bulacu-Talnariu A., Temereanca A., Ruta S., Letendre S., Ene L., Achim C. Plasma IP-10: a potential biomarker of HAND in HIV plus women. Journal of Neurovirology 2018, 24, S10-S10.

55.      Burlacu R., Umlauf A., Marcotte T., Soontornniyomkij B., Diaconu C., Bulacu-Talnariu A., Temereanca A., Ruta S., Letendre S., Ene L., Achim C. Plasma IP-10: a potential biomarker of HAND in HIV plus women. Journal of Neuroimmune Pharmacology 2018, 13, S10-S10.

54.      Florian P.E., Lazar C., Milac A., Evans R., Ruta S., Nichita N., Roseanu A. Lactoferrin-derived peptides with anti-hepatitis B virus properties. Febs Journal 2017, 284, 324-324.

53.      Sultana C., Oprisan G., Grancea C., Teleman M.D., Oprea C., Florescu S., Dinu S., Ceausu E., Ruta S. Interferon-gamma Inducible Protein 10-biomarker for treatment outcome in chronic hepatitis C. Romanian Biotechnological Letters 2017, 22, 13155-13162.

52.      Siliste R., Cristescu C.C., Dita C., Vintila A.M., Grancea C., Ruta S. The impact of chronic cytomegalovirus infection on left ventricular hypertrophy. European Journal of Heart Failure 2017, 19, 499-500.

51.      Temereanca A., Oprea C., Wertheim J.O., Ianache I., Ceausu E., Cernescu C., Mehta S.R., Ruta S. HIV transmission clusters among injecting drug users in Romania. Romanian Biotechnological Letters 2017, 22, 12307-12315.

50.      Popescu C.P., Florescu S.A., Lupulescu E., Zaharia M., Tardei G., Lazar M., Ceausu E., Ruta S.M. Neurologic Complications of Influenza B Virus Infection in Adults, Romania. Emerging Infectious Diseases 2017, 23, 574-581, doi:10.3201/eid2304.161317.

49.      Chiru D., Mambet C., Matei L., Bleotu C., Ruta S., Diaconu C.C. Delivering the “Blueprints” or “DNA Repairing Kits” Instead of Drugs in the Treatment of Congenital Hemoglobinopathies. Current Organic Chemistry 2017, 21, 74-85, doi:10.2174/1385272820666160511122404.

48.      Sultana C., Oprisan G., Teleman M.D., Dinu S., Oprea C., Voiculescu M., Ruta S., Hepgen 88 Project T. Impact of hepatitis C virus core mutations on the response to interferon-based treatment in chronic hepatitis C. World Journal of Gastroenterology 2016, 22, 8406-8413, doi:10.3748/wjg.v22.i37.8406.

47.      Ene L., Marcotte T.D., Umlauf A., Grancea C., Temereanca A., Bharti A., Achim C.L., Letendre S., Ruta S.M. Latent toxoplasmosis is associated with neurocognitive impairment in young adults with and without chronic HIV infection. Journal of Neuroimmunology 2016, 299, 1-7, doi:10.1016/j.jneuroim.2016.08.003.

46.      Florian P.E., Petrareanu G., Ruta S., Roseanu A. Optimization of Recombinant Lipoic Acid Ligase Expression from Bacterial Cells. Romanian Biotechnological Letters 2016, 21, 11539-11542.

45.      Ruta S., Sultana C., Oprea C., Vagu C., Ceausu E., Cernescu C. HCV non-1b genotypes in injecting drug users from Romania. Journal of Infection in Developing Countries 2016, 10, 523-527, doi:10.3855/jidc.7019.

44.      Ianache I., Calistru P., Tardei G., Ruta S., Oprea C. Late presentation in HIV-infected injecting drug users – a huge challenge for the Romanian health-care system. Romanian Journal of Legal Medicine 2016, 24, 122-127, doi:10.4323/rjlm.2016.122.

43.      Florian P.E., Rouille Y., Ruta S., Nichita N., Roseanu A. Recent advances in human viruses imaging studies. Journal of Basic Microbiology 2016, 56, 591-607, doi:10.1002/jobm.201500575.

42.      Popescu C.P., Ceausu E., Florescu S.A., Chirita D., Ruta S. COMPLICATIONS OF VARICELLA IN UNVACCINATED CHILDREN FROM ROMANIA, 2002-2013. Pediatric Infectious Disease Journal 2016, 35, 211-212, doi:10.1097/inf.0000000000000969.

41.      Rosca A., Anton G., Botezatu A., Temereanca A., Ene L., Achim C., Ruta S. miR-29a associates with viro-immunological markers of HIV infection in treatment experienced patients. Journal of Medical Virology 2016, 88, 2132-2137, doi:10.1002/jmv.24586.

40.      Florian P., Lazar C., Nichita N., Galantonu R., Popescu C., Ruta S., Roseanu A. Coumarin labeling of hepatitis B virus. Journal of Viral Hepatitis 2015, 22, 44-44.

39.      Ruta S., Cernescu C. Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes. World Journal of Gastroenterology 2015, 21, 10811-10823, doi:10.3748/wjg.v21.i38.10811.

38.      Comanescu C., Bleotu C., Huica I., Radulescu M., Grancea C., Anton G. Non-invasive method for the evaluation of IL-6 and IL-10 levels in patients with chronic hepatitis C. Romanian Biotechnological Letters 2015, 20, 11018-11024.

37.      Iacob S., Iacob R., Vagu C., Ruta S., Gheorghe C., Popescu I., Gheorghe L. RS199508964 DELETION IN EXON 6 OF IRF5 GENE IS CORRELATED WITH IL28B GENE SNP RS12980275 IN PATIENTS WITH RECURRENT HEPATITIS C FOLLOWING LIVER TRANSPLANTATION. Transplant International 2015, 28, 508-508.

36.      Rosca A., Ene L., Anton G., Temereanca A., Achim C.L., Ruta S.M. MiR-29a: a potential marker of neurocognitive impairment in HIV-infected patients. Journal of Neurovirology 2015, 21, S63-S63.

35.      Ene L., Oliveira M.F., Tardei G., Diaconu C., Grancea C., Soontornniyomkij B., Ruta M.S., Smith D.M., Achim C.L. CMV impact on neurocognitive impairment in a cohort of Romanian young adults with chronic HIV-infection. Journal of Neurovirology 2015, 21, S19-S19.

34.      Ene L., Marcotte T., Grancea C., Temereanca A., Luca A., Bharti A., Umlauf A., Achim C.L., Letendre S., Ruta S.M. Latent toxoplasmosis is associated with neurocognitive impairment in a cohort of young adults with chronic HIV infection from Romania. Journal of Neurovirology 2015, 21, S18-S19.

33.      Antipa C., Popa M., Marutescu L., Bleotu C., Veronica L., Bertesteanu S., Grigore R., Bezirtzoglou E., Ruta S.M. Virulence Profiles of Bacterial Strains Isolated From Periodontal Lesions. Romanian Biotechnological Letters 2015, 20, 10662-10669.

32.      Bleotu C., Chifiriuc M.C., Pircalabioru G., Bertesteanu S.G., Grigore R., Ruta S.M., Banu O., Lazar V. Significance of serum antibodies against HSP 60 and HSP 70 for the diagnostic of infectious diseases (vol 5, pg 828, 2014). Virulence 2015, 6, 101-101, doi:10.1080/21505594.2015.1012469.

31.      Ene L., Duiculescu D., Tardei G., Ruta S., Smith D.M., Mehta S., Letendre S., Achim C.L. Hepatitis B virus compartmentalization in the cerebrospinal fluid of HIV-infected patients. Clinical Microbiology and Infection 2015, 21, doi:10.1016/j.cmi.2014.11.012.

30.      Florian P.E., Galantonu R.N., Lazar C., Ruta S., Roseanu A., Nichita N. Labeling of hepatitis B virus middle envelope protein with enhanced green fluorescent protein. Romanian Biotechnological Letters 2014, 19, 9974-9983.

29.      Bleotu C., Chifiriuc M.C., Pircalabioru G., Bertesteanu S.V.G., Grigore R., Ruta S.M., Lazar V. Significance of serum antibodies against HSP 60 and HSP 70 for the diagnostic of infectious diseases. Virulence 2014, 5, 828-831, doi:10.4161/21505594.2014.973800.

28.      Oprea C., Ianache I., Radoi R., Erscoiu S., Tardei G., Nicolaescu O., Nica M., Calistru P., Ruta S., Ceausu E. Alarming increase in tuberculosis and hepatitis C virus (HCV) among HIV infected intravenous drug users. Journal of the International Aids Society 2014, 17, 90-90, doi:10.7448/ias.17.4.19625.

27.      Cernescu E., Ruta S., Botezatu A., Anton G., Cernescu C. Impact of education level and life-style related factors on high-risk human papilomaviruses infections. Romanian Biotechnological Letters 2014, 19, 9272-9279.

26.      Vagu C., Sultana C., Ruta S. Serum Iron Markers in Patients With Chronic Hepatitis C Infection. Hepatitis Monthly 2013, 13, doi:10.5812/hepatmon.13136.

25.      Ene L., Duiculescu D., Radoi R., Tardei G., Nica M., Ruta S., Ellis R., Grant I., Achim C. High frequency of HIV-related neurologic complications in a Romanian cohort of children and young adults infected with subtype F. Journal of Neurovirology 2013, 19, S26-S26.

24.      Oprea C., Ceausu E., Ruta S. Ongoing outbreak of multiple blood-borne infections in injecting drug users in Romania. Public Health 2013, 127, 1048-1050, doi:10.1016/j.puhe.2013.08.018.

23.      Temereanca A., Ene L., Mehta S., Manolescu L., Duiculescu D., Ruta S. Transmitted HIV drug resistance in treatment-naive Romanian patients. Journal of Medical Virology 2013, 85, 1139-1147, doi:10.1002/jmv.23572.

22.      Sultana C., Erscoiu S.M., Grancea C., Ceausu E., Ruta S. Predictors of Chronic Hepatitis C Evolution in HIV Co-Infected Patients From Romania. Hepatitis Monthly 2013, 13, doi:10.5812/hepatmon.8611.

21.      Bleotu C., Chifiriuc M.C., Grigore R., Grancea C., Popescu C.R., Anton G., Cernescu C. Investigation of Th1/Th2 cytokine profiles in patients with laryngo-pharyngeal, HPV-positive cancers. European Archives of Oto-Rhino-Laryngology 2013, 270, 711-718, doi:10.1007/s00405-012-2067-7.

20.      Sultana C., Erscoiu S.M., Ceausu E., Ruta S. HIV/HCV coinfection in Romania – can we afford not to treat? Journal of Gastrointestinal and Liver Diseases 2012, 21, 441-442.

19.      Sultana C., Oprisan G., Szmal C., Vagu C., Temereanca A., Dinu S., Teleman M.D., Ruta S. Molecular Epidemiology of Hepatitis C Virus Strains from Romania. Journal of Gastrointestinal and Liver Diseases 2011, 20, 261-266.

18.      Sultana C., Vagu C., Temereanca A., Grancea C., Slobozeanu J., Ruta S. Hepatitis C virus genotypes in injecting drug users from Romania. Central European Journal of Medicine 2011, 6, 672-678, doi:10.2478/s11536-011-0073-6.

17.      Manolescu L., Temereanca A., Diaconu C.C., Ruta S. Correlation between resistance profile and immunosuppression in heavily treated HIV-1 infected Romanian patients. Romanian Biotechnological Letters 2011, 16, 6439-6449.

16.      Olteanu R., Grancea C., Ardeleanu C., Balanescu E., Balanescu P. Interleukin-17A mediated inflammation in cutaneous lupus erythematosus. Journal of the American Academy of Dermatology 2011, 64, AB27-AB27.

15.      Tanasescu C., Balanescu E., Balanescu P., Olteanu R., Badea C., Grancea C., Vagu C., Bleotu C., Ardeleanu C., Georgescu A. IL-17 in cutaneous lupus erythematosus. European Journal of Internal Medicine 2010, 21, 202-207, doi:10.1016/j.ejim.2010.03.004.

14.      Alexiu I., Tardei G., Luca C., Chivu M., Sultana C., Grancea C., Stoian M., Diaconu C. Interleukin-6, tumor necrosis factor-alpha polymorphisms and HBV infection status in two transplant patient groups. Febs Journal 2010, 277, 52-52.

13.      Ruta S., Ene L., Temereanca A., Manolescu L., Tardei G., Ceausu E., Duiculescu D. Possible independent replication of HBV in the CNS of HIV-1 infected patients. Journal of Clinical Virology 2009, 46, S7-S8, doi:10.1016/s1386-6532(09)70051-4.

12.      Sultana C., Manolescu L., Ruta S. Evaluation of Early Predictors of Successful Therapy in HCV Infected Patients from Romania. International Journal of Infectious Diseases 2008, 12, E427-E427, doi:10.1016/j.ijid.2008.05.1254.

11.      Ruta S., Sultana C., Manolescu L., Tardei G., Motoc A., Brehar-Cioflec D., Szmal C., Dinu S., Oprisoreanu A.M., Oprisan G. The Changing Profile of Circulating HCV Genotypes in Romania. International Journal of Infectious Diseases 2008, 12, E94-E94, doi:10.1016/j.ijid.2008.05.235.

10.      Chivu M., Nastasia S., Sultana C., Bleotu C., Alexiu I., Hudita D. Optimizing donor selection in order to establish a cord blood banking facility: maternal and obstetric factors impact. Central European Journal of Medicine 2007, 2, 180-189, doi:10.2478/s11536-007-0018-2.

9.         Manolescu L., Sultana C., Marinescu P., Ruta S. P1895 Low prevalence of HCV co-infection in HIV/HBV co–infected teenagers from Romania. International Journal of Antimicrobial Agents 2007, S543.

8.         Kozinetz C.A., Matusa R., Ruta S., Hacker C.S., Cernescu C., Cazacu A. Alternatives to HIV-RNA and CD4 count to monitor HIV disease progression: A prospective cohort study in Romania. Journal of Medical Virology 2005, 77, 159-163, doi:10.1002/jmv.20433.

7.         Kozinetz C., Matusa R., Ruta S., Cernescu C., Hacker C., Cazacu A. Alternative to HIV-RNA and CD4 count to monitor HIV disease progression: A prospective cohort study in Romania. American Journal of Epidemiology 2004, 159, S40-S40.

6.         Matusa R.F., Ruta S.M., Sultana C., Manolescu L., Cernescu C., Medimond. Blood uric acid level and gender differences in the pathogenesis of HIV infection. In Proceedings of the 15th International AIDS Conference, Bangkok, THAILAND, Jul 11-17, 2004; pp. 119-121.

5.         Diaconu C.C., Bleotu C., Chivu M., Alexiu I., Petrusca D., Anton G., Achim R., Ruta S.M., Cernescu C. The development of larger cells that spontaneously escape senescence – a step during the immortalization of a human cancer cell line. Journal of Cellular and Molecular Medicine 2004, 8, 93-101, doi:10.1111/j.1582-4934.2004.tb00263.x.

4.         Tardei G., Ruta S., Chitu V., Rossi C., Tsai T.F., Cernescu C. Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile virus infection. Journal of Clinical Microbiology 2000, 38, 2232-2239.

3.         Cernescu C., Nedelcu N.I., Tardei G., Ruta S., Tsai T.F. Continued transmission of West Nile virus to humans in southeastern Romania, 1997-1998. Journal of Infectious Diseases 2000, 181, 710-712, doi:10.1086/315225.

2.         Tsai T.F., Popovici F., Cernescu C., Campbell G.L., Nedelcu N.I., Laurentia V., Spantulescu L., Chitu V., Ruta S., Tardei G., Craciun D., Nicolaiciuc D., Pitigoi D., Ceianu C., Nicolescu G., Ungureanu A., Vladimirescu L.A., Deubel V., Leguenno B., Han L., Savage H., Tengelsen L., Tengelsen E.A., Knauert F., Mangiafico J.A., Rossi C., Investigative T. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998, 352, 767-771, doi:10.1016/s0140-6736(98)03538-7.

1.         Cernescu C.E., Tardei G., Necula A., Ruta S.M., Pau C.P. THE SEROLOGIC SIGNIFICANCE OF F-VIRAL GENOTYPE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EPIDEMIC. Journal of Infectious Diseases 1994, 170, 1043-1044, doi:10.1093/infdis/170.4.1043.